Myocarditis stands as a medical condition marked by inflammation in the myocardium, which is the heart muscle. The inflammation commonly stems from viral infections, although bacterial or fungal infections, certain medications, or exposure to toxins can also trigger it. This inflammatory response weakens the heart muscle, impacting its ability to effectively pump blood. Symptoms of myocarditis can manifest in various ways, ranging from mild fatigue and chest discomfort to more severe complications like heart failure or irregular heart rhythms. To diagnose myocarditis, a comprehensive approach is typically employed, involving a thorough review of the patient's medical history, a detailed physical examination, blood tests, and various imaging studies. While mild cases may resolve spontaneously, more severe instances may necessitate medical intervention, including the use of medications aimed at reducing inflammation and supporting heart function. Due to the diverse array of causes and potential complications associated with myocarditis, early detection and appropriate management are paramount in addressing the condition and preventing long-term cardiac issues.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation